Maria I Amodio-Groton

机构：Paratek Pharmaceuticals (United States) · ORCID：0000-0002-4846-9284

发表论文 19 篇 · 总被引 696 次 · h-index 11

代表论文

• Safety of High‐Dose Intravenous Daptomycin Treatment: Three‐Year Cumulative Experience in a Clinical Program (2009 · Clinical Infectious Diseases · 被引 154)
• Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy (2009 · Annals of Pharmacotherapy · 被引 134)
• Multicenter Evaluation of the Clinical Outcomes of Daptomycin with and without Concomitant β-Lactams in Patients with Staphylococcus aureus Bacteremia and Mild to Moderate Renal Impairment (2012 · Antimicrobial Agents and Chemotherapy · 被引 95)
• Sequential Parenteral and Oral Ciprofloxacin Regimen versus Parenteral Therapy for Bacteremia: A Pharmacoeconomic Analysis (1996 · Annals of Pharmacotherapy · 被引 70)
• Adverse Reactions to Trimethoprim/Sulfamethoxazole in AIDS (2003 · Annals of Pharmacotherapy · 被引 51)
• Antimicrobial agents for the dermatologist. II. Macrolides, fluoroquinolones, rifamycins, tetracyclines, trimethoprim-sulfamethoxazole, and clindamycin (1997 · Journal of the American Academy of Dermatology · 被引 44)